NIKOLETA GIARIMOGLOU

Dr. NIKOLETA GIARIMOGLOU

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 November 2019 in Nature Structural & Molecular Biology
Verified
Journal Article
Closed access
PDF file
SLShuang Li
Shuang Li
ZSZhaoming Su
Zhaoming Su
JLJean Lehmann
Jean Lehmann
VSVassiliki Stamatopoulou
Vassiliki Stamatopoulou
NGNIKOLETA GIARIMOGLOU
NIKOLETA GIARIMOGLOU
Jinwei ZhangJinwei Zhang
Jinwei Zhang

13 September 2022 in Antibiotics
Verified
Journal Article
Open access
PDF file
NGNIKOLETA GIARIMOGLOU
NIKOLETA GIARIMOGLOU
AKADAMANTIA KOUVELA
ADAMANTIA KOUVELA
AMAlexandros Maniatis
Alexandros Maniatis
Athanasios PapakyriakouAthanasios Papakyriakou
Athanasios Papakyriakou
Jinwei ZhangJinwei Zhang
Jinwei Zhang
Constantinos STATHOPOULOSConstantinos STATHOPOULOS
Constantinos STATHOPOULOS
Riboswitches are structured non-coding RNAs found in the 5′ UTR of important genes for bacterial metabolism, virulence and survival. Upon the binding of specific ligands that can vary from simple ions to complex molecules such as nucleotides and tRNAs, riboswitches change their local and global mRNA conformations to affect downstream transcription or translation. Due to their dynamic nature and central regulatory role in bacterial metabolism, riboswitches have been exploited as novel RNA-based targets for the development of new generation antibacterials that can overcome drug-resistance problems. During recent years, several important riboswitch structures from many bacterial representatives, including several prominent human pathogens, have shown that riboswitches are ideal RNA targets for new compounds that can interfere with their structure and function, exhibiting much reduced resistance over time. Most interestingly, mainstream antibiotics that target the ribosome have been shown to effectively modulate the regulatory behavior and capacity of several riboswitches, both in vivo and in vitro, emphasizing the need for more in-depth studies and biological evaluation of new antibiotics. Herein, we summarize the currently known compounds that target several main riboswitches and discuss the role of mainstream antibiotics as modulators of T-box riboswitches, in the dawn of an era of novel inhibitors that target important bacterial regulatory RNAs.

Verified
Journal Article
Open access
PDF file
EKEleni Kaliatsi
Eleni Kaliatsi
NGNIKOLETA GIARIMOGLOU
NIKOLETA GIARIMOGLOU
Constantinos STATHOPOULOSConstantinos STATHOPOULOS
Constantinos STATHOPOULOS
VSVassiliki Stamatopoulou
Vassiliki Stamatopoulou
Ribosomal RNA (rRNA) biogenesis takes place in the nucleolus, the most prominent condensate of the eukaryotic nucleus. The proper assembly and integrity of the nucleolus reflects the accurate synthesis and processing of rRNAs which in turn, as major components of ribosomes, ensure the uninterrupted flow of the genetic information during translation. Therefore, the abundant production of rRNAs in a precisely functional nucleolus is of outmost importance for the cell viability and requires the concerted action of essential enzymes, associated factors and epigenetic marks. The coordination and regulation of such an elaborate process depends on not only protein factors, but also on numerous regulatory non-coding RNAs (ncRNAs). Herein, we focus on RNA-mediated mechanisms that control the synthesis, processing and modification of rRNAs in mammals. We highlight the significance of regulatory ncRNAs in rRNA biogenesis and the maintenance of the nucleolar morphology, as well as their role in human diseases and as novel druggable molecular targets.

17 May 2022 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
NGNIKOLETA GIARIMOGLOU
NIKOLETA GIARIMOGLOU
AKAdamantia Kouvela
Adamantia Kouvela
IPIoanna Patsi
Ioanna Patsi
Jinwei ZhangJinwei Zhang
Jinwei Zhang
VSVassiliki Stamatopoulou
Vassiliki Stamatopoulou
Constantinos STATHOPOULOSConstantinos STATHOPOULOS
Constantinos STATHOPOULOS
T-box riboswitches (T-boxes) are essential RNA regulatory elements with a remarkable structural diversity, especially among bacterial pathogens. In staphylococci, all glyS T-boxes synchronize glycine supply during synthesis of nascent polypeptides and cell wall formation and are characterized by a conserved and unique insertion in their antiterminator/terminator domain, termed stem Sa. Interestingly, in Staphylococcus aureus the stem Sa can accommodate binding of specific antibiotics, which in turn induce robust and diverse effects on T-box-mediated transcription. In the present study, domain swap mutagenesis and probing analysis were performed to decipher the role of stem Sa. Deletion of stem Sa significantly reduces both the S. aureus glyS T-box-mediated transcription readthrough levels and the ability to discriminate among tRNAGly isoacceptors, both in vitro and in vivo. Moreover, the deletion inverted the previously reported stimulatory effects of specific antibiotics. Interestingly, stem Sa insertion in the terminator/antiterminator domain of Geobacillus kaustophilus glyS T-box, which lacks this domain, resulted in elevated transcription in the presence of tigecycline and facilitated discrimination among proteinogenic and nonproteinogenic tRNAGly isoacceptors. Overall, stem Sa represents a lineage-specific structural feature required for efficient staphylococcal glyS T-box-mediated transcription and it could serve as a species-selective druggable target through its ability to modulate antibiotic binding.

9 July 2024 in RNA
Verified
Journal Article
Open access
PDF file
NGNIKOLETA GIARIMOGLOU
NIKOLETA GIARIMOGLOU
AKADAMANTIA KOUVELA
ADAMANTIA KOUVELA
Jinwei ZhangJinwei Zhang
Jinwei Zhang
VSVassiliki Stamatopoulou
Vassiliki Stamatopoulou
Constantinos STATHOPOULOSConstantinos STATHOPOULOS
Constantinos STATHOPOULOS
T-box riboswitches are widespread bacterial regulatory noncoding RNAs that directly interact with tRNAs and switch conformations to regulate the transcription or translation of genes related to amino acid metabolism. Recent studies in Bacilli have revealed the core mechanisms of T-boxes that enable multivalent, specific recognition of both the identity and aminoacylation status of the tRNA substrates. However, in-depth knowledge on a vast number of T-boxes in other bacterial species remains scarce, although a remarkable structural diversity, particularly among pathogens, is apparent. In the present study, analysis of T-boxes that control the transcription of glycyl–tRNA synthetases from four prominent human pathogens revealed significant structural idiosyncrasies. Nonetheless, these diverse T-boxes maintain functional T-box:tRNAGlyinteractions both in vitro and in vivo. Probing analysis not only validated recent structural observations, but also expanded our knowledge on the substantial diversities among T-boxes and suggest interesting distinctions from the canonical Bacilli T-boxes. Surprisingly, some glycyl T-boxes seem to redirect the T-box trajectory in the absence of recognizable K-turns or contain Stem II modules that are generally absent in glycyl T-boxes. These results consolidate the notion of a lineage-specific diversification and elaboration of the T-box mechanism and corroborate the potential of T-boxes as promising species-specific RNA targets for next-generation antibacterial compounds.

17 September 2025 in RNA
Verified
Journal Article
Open access
PDF file
NGNIKOLETA GIARIMOGLOU
NIKOLETA GIARIMOGLOU
AKADAMANTIA KOUVELA
ADAMANTIA KOUVELA
Athanasios PapakyriakouAthanasios Papakyriakou
Athanasios Papakyriakou
Jinwei ZhangJinwei Zhang
Jinwei Zhang
VSVassiliki Stamatopoulou
Vassiliki Stamatopoulou
Constantinos STATHOPOULOSConstantinos STATHOPOULOS
Constantinos STATHOPOULOS
T-box riboswitches belong to a specific class of RNA regulatory elements that control gene expression in Gram-positive bacteria, including prominent human pathogens. They sense the availability of amino acids by detecting the aminoacylation status of their cognate tRNAs and regulate the expression of genes involved in aminoacylation, amino acid transport, and metabolism. Recent advances in the structures and mechanisms of several regulatory noncoding RNAs among pathogenic bacteria have garnered attention for the development of a new generation of species-specific antibacterials. The frequently acquired resistance against current antibiotics has emerged as a significant challenge for healthcare systems and a serious threat to public health. Herein, we report the characterization of an effective T-box riboswitch inhibitor, termed T-box-i, which efficiently disrupts T-box riboswitch-mediated transcription in vivo. T-box-i was selected through a virtual screening campaign of commercially available small molecules against high-resolution crystallographic structures of T-box riboswitches. It exhibited no cytotoxicity in mammalian cells nor induced antibiotic resistance in Staphylococcus aureus cultures. These findings provide valuable insights into exploiting T-box riboswitches as antibiotic targets and underscore the therapeutic potential of compounds that selectively target extensively structured regulatory RNA elements and interfaces to combat drug-resistant pathogens.